GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » EV-to-Revenue

Creative Medical Technology Holdings (Creative Medical Technology Holdings) EV-to-Revenue : -454.00 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Creative Medical Technology Holdings's enterprise value is $-4.09 Mil. Creative Medical Technology Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01 Mil. Therefore, Creative Medical Technology Holdings's EV-to-Revenue for today is -454.00.

The historical rank and industry rank for Creative Medical Technology Holdings's EV-to-Revenue or its related term are showing as below:

CELZ' s EV-to-Revenue Range Over the Past 10 Years
Min: -490.84   Med: 20.42   Max: 2777
Current: -454

During the past 13 years, the highest EV-to-Revenue of Creative Medical Technology Holdings was 2777.00. The lowest was -490.84. And the median was 20.42.

CELZ's EV-to-Revenue is ranked better than
99.62% of 1039 companies
in the Biotechnology industry
Industry Median: 8.37 vs CELZ: -454.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Creative Medical Technology Holdings's stock price is $4.35. Creative Medical Technology Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01. Therefore, Creative Medical Technology Holdings's PS Ratio for today is 725.00.


Creative Medical Technology Holdings EV-to-Revenue Historical Data

The historical data trend for Creative Medical Technology Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings EV-to-Revenue Chart

Creative Medical Technology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.98 133.70 37.33 -146.46 -406.06

Creative Medical Technology Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -146.46 -101.61 -93.75 -205.19 -406.06

Competitive Comparison of Creative Medical Technology Holdings's EV-to-Revenue

For the Biotechnology subindustry, Creative Medical Technology Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's EV-to-Revenue falls into.



Creative Medical Technology Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Creative Medical Technology Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-4.086/0.009
=-454.00

Creative Medical Technology Holdings's current Enterprise Value is $-4.09 Mil.
Creative Medical Technology Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Medical Technology Holdings  (NAS:CELZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Creative Medical Technology Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.35/0.006
=725.00

Creative Medical Technology Holdings's share price for today is $4.35.
Creative Medical Technology Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Medical Technology Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Headlines

From GuruFocus

Creative Medical Technology Holdings Provides Corporate Update

By PRNewswire PRNewswire 06-12-2023